Intercept Pharmaceuticals Inc Debt/Equity
What is the Debt/Equity of Intercept Pharmaceuticals Inc?
The Debt/Equity of Intercept Pharmaceuticals Inc is 7.17
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with debt/equity similar to Intercept Pharmaceuticals Inc
- OceanFirst has Debt/Equity of 7.15
- Mid-Southern Savings Bank, FSB has Debt/Equity of 7.15
- BayCom Corp has Debt/Equity of 7.16
- BGMC International has Debt/Equity of 7.16
- CRCAM Alpes Provence has Debt/Equity of 7.17
- KLDiscovery has Debt/Equity of 7.17
- Intercept Pharmaceuticals Inc has Debt/Equity of 7.17
- Manpasand Beverages has Debt/Equity of 7.19
- First Merchants has Debt/Equity of 7.19
- Sunshine Oilsands has Debt/Equity of 7.19
- China SCE Property has Debt/Equity of 7.20
- National Bank Corp has Debt/Equity of 7.20
- Argo International Ltd has Debt/Equity of 7.21